{"disease":{"id":"pancreatic-head-tumour","name":"pancreatic head tumour"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07144917","title":"Immunoparalysis After Pancreaticoduodenectomy","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05605522","title":"A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":19,"lead_sponsor_name":"3B Pharmaceuticals GmbH","has_results":false},{"nct_id":"NCT03525392","title":"Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"Ipsen","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}